• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Containment, Contact Tracing and Asymptomatic Transmission of Novel Coronavirus Disease (COVID-19): A Modelling Study

tetano

Editor, Senior Moderator
J Clin Med


. 2020 Sep 27;9(10):E3125.
doi: 10.3390/jcm9103125.
Containment, Contact Tracing and Asymptomatic Transmission of Novel Coronavirus Disease (COVID-19): A Modelling Study


Ryo Kinoshita[SUP] 1 2 [/SUP], Asami Anzai[SUP] 1 2 [/SUP], Sung-Mok Jung[SUP] 1 2 [/SUP], Natalie M Linton[SUP] 1 2 [/SUP], Takeshi Miyama[SUP] 3 [/SUP], Tetsuro Kobayashi[SUP] 1 2 [/SUP], Katsuma Hayashi[SUP] 1 2 [/SUP], Ayako Suzuki[SUP] 1 2 [/SUP], Yichi Yang[SUP] 2 [/SUP], Andrei R Akhmetzhanov[SUP] 2 [/SUP], Hiroshi Nishiura[SUP] 1 2 4 [/SUP]



Affiliations

Abstract

When a novel infectious disease emerges, enhanced contact tracing and isolation are implemented to prevent a major epidemic, and indeed, they have been successful for the control of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which have been greatly reduced without causing a global pandemic. Considering that asymptomatic and pre-symptomatic infections are substantial for the novel coronavirus disease (COVID-19), the feasibility of preventing the major epidemic has been questioned. Using a two-type branching process model, the present study assesses the feasibility of containing COVID-19 by computing the probability of a major epidemic. We show that if there is a substantial number of asymptomatic transmissions, cutting chains of transmission by means of contact tracing and case isolation would be very challenging without additional interventions, and in particular, untraced cases contribute to lowering the feasibility of containment. Even if isolation of symptomatic cases is conducted swiftly after symptom onset, only secondary transmissions after the symptom onset can be prevented.

Keywords: asymptomatic; containment; emerging infectious diseases; epidemiology.
 
Back
Top Bottom